Page last updated: 2024-11-04

risedronic acid and Neoplasms, Pleural

risedronic acid has been researched along with Neoplasms, Pleural in 1 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dell'Anno, I1
Martin, SA1
Barbarino, M1
Melani, A1
Silvestri, R1
Bottaro, M1
Paolicchi, E1
Corrado, A1
Cipollini, M1
Melaiu, O1
Giordano, A1
Luzzi, L1
Gemignani, F1
Landi, S1

Other Studies

1 other study available for risedronic acid and Neoplasms, Pleural

ArticleYear
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
    Investigational new drugs, 2021, Volume: 39, Issue:3

    Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Drug Repositioning; Gene Expres

2021
chemdatabank.com